%0 Journal Article
%T Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada
%A Barbara Ramos
%A Jameel Nazir
%A Sender Herschorn
%A Zalmai Hakimi
%J Archive of "Canadian Urological Association Journal".
%D 2017
%R 10.5489/cuaj.4114
%X This analysis compared the cost-effectiveness of once-daily regimens of mirabegron 50 mg and generic tolterodine ER 4 mg in a hypothetical cohort of previously treated patients with overactive bladder (OAB) in Canada
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434500/